• Fund Type: Open-End Fund
  • Objective: Growth Large Cap
  • Asset Class: Equity
  • Geographic Focus: U.S.

Columbia Select Large Cap Growth Fund

+ Add to Watchlist

CSLWX:US

17.79 USD 0.15 0.85%

As of 09:29:30 ET on 12/26/2014.

Snapshot for Columbia Select Large Cap Growth Fund (CSLWX)

Year To Date: +9.90% 3-Month: +5.04% 3-Year: +21.80% 52-Week Range: 15.11 - 18.02
1-Month: -1.09% 1-Year: +9.96% 5-Year: - Beta vs RLG: 1.15

Mutual Fund Chart for CSLWX

No chart data available.
  • CSLWX:US 17.79
  • 1M
  • 1Y
Interactive CSLWX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CSLWX

Columbia Select Large Cap Growth Fund is an open-end fund incorporated in the USA. The Fund's objective is superior, long-term capital appreciation. The Fund invests at least 80% of its net assets in common stocks of large U.S. companies that have market capitalizations of companies included in the Russell 1000 Growth Index.

Inception Date: 09-27-2010 Telephone: 1-800-345-6611
Managers: THOMAS M GALVIN / RICHARD A CARTER
Web Site: www.columbiafunds.com

Fundamentals for CSLWX

NAV (on 2014-12-26) 17.79
Assets (M) (on 2014-12-26) 6,964.32
Fund Leveraged N
Minimum Investment 500.00
Minimum Subsequent Investment 0.00

Dividends for CSLWX

No dividends reported

Fees & Expenses for CSLWX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.59
Redemption Fee -
12b1 Fee 0.25
Expense Ratio 1.11

Top Fund Holdings for CSLWX

Filing Date: 10/31/2014
Name Position Value % of Total
LinkedIn Corp 1,417,629 324,580,336 4.530%
Illumina Inc 1,681,616 323,845,609 4.520%
Priceline Group Inc/The 259,136 312,572,435 4.363%
Vertex Pharmaceuticals Inc 2,713,163 305,610,680 4.266%
Pharmacyclics Inc 2,286,689 298,801,652 4.170%
Visa Inc 1,135,043 274,033,431 3.825%
salesforce.com inc 4,223,466 270,259,589 3.772%
Celgene Corp 2,510,104 268,807,037 3.752%
Amazon.com Inc 876,168 267,634,277 3.735%
Biogen Idec Inc 823,594 264,439,562 3.691%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil